Erfandel (Erdafitinib Tablet) 3mg

Erfandel (Erdafitinib) 3mg tablets are prescribed for managing certain types of cancer. This oral medication is taken once daily to help slow disease progression. Erfandel belongs to a class of targeted therapies designed for specific cancer treatments.

Strength

3mg

Pack Size

56s

Storage

Ambient

Manufacturer / TM Owner

Janssen-Cilag Farmacêutica Ltda.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Erfandel (Erdafitinib) 3mg tablets are used in the treatment of urothelial carcinoma, a type of bladder cancer. It targets specific genetic mutations to help control cancer cell growth. Patients with metastatic or locally advanced cancer may benefit from this therapy. Erfandel is typically considered when other treatments have not been effective.

Side Effects

Erfandel (Erdafitinib) 3mg tablets work by blocking signals that promote cancer cell growth. Common effects include mild nausea or fatigue, which may vary by individual. Some users report digestive discomfort or changes in taste while taking this medication. These effects are generally manageable and temporary.

Precautions & Warnings

Keep Erfandel (Erdafitinib) 3mg tablets in a cool, dry place away from direct sunlight. Store the medication in its original packaging to protect it from moisture. Always handle tablets with dry hands to prevent contamination. If a dose is missed, follow the prescribed schedule or consult a healthcare provider for guidance.

Avoid Interactions

Erfandel (Erdafitinib) 3mg tablets may interact with certain medications, including strong CYP3A4 inhibitors or inducers. Grapefruit products can affect how the body processes this drug, so avoid consuming them. Always inform your healthcare provider about all medications and supplements you are taking. Some interactions may require dose adjustments or alternative treatments.

Frequently Asked Questions

Erfandel (Erdafitinib) 3mg tablets are used to treat certain types of bladder cancer, specifically urothelial carcinoma.

Store Erfandel 3mg tablets in a cool, dry place away from moisture and direct sunlight.

Consult a healthcare provider before combining Erfandel with other drugs, as interactions may occur.

Common effects may include mild nausea, fatigue, or digestive discomfort.

No, Erfandel requires a prescription and is not available over the counter.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.